T. Rowe Price Associates »

Outlook Therapeutics shares owned by T. Rowe Price Associates

Quarter-by-quarter ownership of Outlook Therapeutics shares owned by T. Rowe Price Associates from 13F filings

Historical chart of T. Rowe Price Associates investment in Outlook Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Outlook Therapeutics held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Outlook Therapeutics by T. Rowe Price Associates

Quarter filed Position value Share count Share price at filing
2023-12-31 $14k 33k 0.42
2023-09-30 $8.0k 33k 0.24
2023-06-30 $51k 29k 1.75
2023-03-31 $32k 29k 1.10
2022-12-31 $21k 19k 1.09

More positions owned by T. Rowe Price Associates

Microsoft Corp Comm Stk (MSFT)
Apple Comm Stk (AAPL)
Amazon Comm Stk (AMZN)
Nvidia Corporation Comm Stk (NVDA)
Meta Platforms Comm Stk (META)
Alphabet Comm Stk (GOOGL)
Alphabet Comm Stk (GOOG)
Unitedhealth Group Comm Stk (UNH)
Eli Lilly & Co Comm Stk (LLY)
Visa Comm Stk (V)
Mastercard Incorporated Comm Stk (MA)
Tesla Comm Stk (TSLA)
Intuit Comm Stk (INTU)
Servicenow Comm Stk (NOW)
Fiserv Comm Stk (FI)

View all positions for T. Rowe Price Associates

Top funds holding Outlook Therapeutics

Vanguard Group
Charles Schwab Investment Management
Rosalind Advisors
Scotia Capital
Millennium Management
Bank of America Corporation
Barclays
Rhumbline Advisers
Gables Capital Management
UBS Group
Ancora Advisors
Jpmorgan Chase & Co
Alliancebernstein
American International
Captrust Financial Advisors

View all funds holding Outlook Therapeutics